Trial intelligence / Profile preview

Phase II trial of ALH-L1005 in chronic periodontitis

KCT0005358Phase 2Recruiting

Sponsor
AngioLab, Inc.
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of AL102-PDT in chronic periodontitis, sponsored by AngioLab, Inc.. Started Jul 2020; status: recruiting.

02

Drugs

AL102-PDT
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on KCT0005358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0005358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call